Lyra Therapeutics (LYRA) Misses Q1 EPS by 1c
Tweet
Share
E-mailGet Alerts LYRA Hot Sheet
Join SI Premium – FREE
Lyra Therapeutics (NASDAQ: LYRA) reported Q1 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12).
For earnings history and earnings-related data on Lyra Therapeutics (LYRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark Reiterates Buy Rating on Marvell (MRVL) Following Earnings
- Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
- Rubrik Inc (RBRK) PT Raised to $114 at Piper Sandler
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
